Series A biotech investors in the UK
Venture-stage companies have raised several rounds and are typically at Series A or beyond, where institutional funds lead and earlier angels follow on. Life sciences companies tend to raise fewer but larger rounds, often backed by university venture arms, specialist funds and Innovate UK grants. Many show a long gap between first funding and later rounds. 373 investor-backed series a life sciences and biotech companies are in Pulse, and 21 raised a first funding round in the last year.
- Investor-backed companies
- 373
- Active investors, 2 years
- 2,863
- Rounds, 2 years
- 588
- Median round
- £326k
Who is investing
In the last two years 623 funds, firms and family offices and 2,229 angels took shares in series a life sciences and biotech companies, with the latest round in Oct 2026. These are the firms backing the most of these companies:
| Firm | Type | Companies |
|---|---|---|
| SFC Capital | Fund or investment firm | 26 companies |
| MNL Parkwalk | Fund or investment firm | 21 companies |
| The Chancellor, Masters and Scholars of the University of Oxford | University | 20 companies |
| SyndicateRoom | Fund or investment firm | 15 companies |
| Old College Capital Holdings Limited | Fund or investment firm | 10 companies |
| The Chancellor, Masters and Scholars of the University of Cambridge | University | 10 companies |
| The UK Innovation & Science Seed Fund LP | Fund or investment firm | 10 companies |
| University of Bristol | University | 10 companies |
See all 2,863 active investors, including angels, with what they've backed, estimated cheque sizes and who they invest alongside.
Rounds and valuations
Over the last two years, 588 funding rounds were raised by series a life sciences and biotech companies, an estimated £595.0m, with a median round of about £326k. 21 of the companies raised their first priced round in the last 12 months. 32% of these valuations carry a High confidence rating.
How Life sciences and biotech compares
Life sciences and biotech companies make up 1% of the 74,284 investor-backed companies in Pulse. The median round of £326k is above the £176k median for the whole UK market. The most active firm in these companies is SFC Capital, in 26 companies.
Questions
How many investors back series a life sciences and biotech companies?
Pulse found 2,863 outside investors taking shares in series a life sciences and biotech companies in the last two years: 623 funds, firms and family offices, and 2,229 angels.
How much do series a life sciences and biotech companies raise?
Over the last two years 588 rounds were raised, an estimated £595.0m in total. The median round was about £326k.
How accurate are the amounts?
They are Pulse estimates, each with a confidence rating. 32% of recent valuations here carry a High confidence rating; the rest are marked Medium or Low.
Can I see every investor?
Pulse subscribers see every outside investor by name, with portfolios and co-investors, from £39.99 a month plus VAT (£47.99 inc. VAT). Contact details are not included and names are not linked to personal profiles.